FDA Investigator CDR Jeremy L Wally, PhD
CDR Jeremy L Wally, PhD has inspections in 4 countries as of 23 Jun 2023. CDR Jeremy L Wally, PhD has collaborated with a combinined 2062 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Belgium,
Canada
Co-Investigator(s):
Alla Kachko, PhD,
Anastasia I Offordile,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Arie C Menachem,
Audrey Thereset Uy,
Barbara M Frazier,
Brentley S Collins,
Brian S Keefer,
Burnell M Henry,
Cassandra Overking,
CDR Cecily Jones,
Chad R Burger,
Chao Ming Tsai,
Christian D Lynch (CDL),
Christina D Lynch,
Christina J Sauder, PhD,
Christina V Santos,
Christopher J Adams,
Cody D Rickman,
Craig D Zagata,
Cynthia Jim, CSO,
Dave Hafner,
David J Hafner,
Debra J Bennett,
Debra L Pagano,
Destry M Sillivan,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Ellen Huang,
Freddy Ortiz Colon,
Gene D Arcy,
Hala L Selby,
Haruhiko Murata,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
James M Mason,
Jean Lhu Primmer,
Joan A Loreng,
Joan Adamo,
Joanne M Hajoway,
Joseph George,
Julianne C Mccullough,
Junho Pak,
Karyn M Campbell,
Kathleen B Mihalik,
Kathryn Carbone, MD,
Kelly N Kerr,
Kenneth M Gordon,
Kristen D Evans,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Margaret E Digennaro,
Linda Thai,
Lisa Feela,
Lisa M Bellows,
LT John M Mastalski,
Marcellinus D Dordunoo,
Marian E Major, PhD,
Mark I Schwartz,
Martha T Olone,
Michael Curbag,
Michael Gurbarg,
Michael J Vardon,
Michele Perry Williams,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mizanne E Lewis,
Nawab A Siddiqui,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paul D Keller,
Paul W Keller,
Paula A Trost,
Peggy M Speight,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Ramon E Martinez,
Randa Melhem, PhD,
Rebecca K Olin,
Robert B Shibuya, MD,
Robert D Tollefsen,
Rose M Ashley,
Scott E Norris,
Scott T Ballard,
Sean R Bryd,
Seneca D Toms,
Shawn E Larson,
Sheila Dreher Lesnick,
Sherry G Bous,
Shuang Tang,
Simone E Pitts,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven A Rubin,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu,
Susant Hadman,
Tammy L Chavis,
Tina S Roecklein,
Uttaniti Limchumroon (Tom),
Vlada Matusovsky,
Wei Wang, PhD,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Xiaokuang Lai, PhD,
Yonggang Wang, PhD
CDR Jeremy L Wally, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2015 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2015-06-26 |
| June, 2022 | FDA 483 | Seqirus Inc - Form 483, 2022-06-09 |
| January, 2014 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2014-01-17 |
| April, 2021 | FDA 483 Response | Emergent Manufacturing Operations Baltimore LLC - Form 483R, 2021-04-30 |
| June, 2022 | FDA 483 Response | Seqirus Inc - Form 483R, 2022-06-24 |
| April, 2021 | FDA 483 | Emergent Manufacturing Operations Baltimore LLC - Form 483, 2021-04-20 |
| June, 2022 | EIR | Seqirus Inc - EIR, 2022-06-09 |
| April, 2021 | EIR | Emergent Manufacturing Operations Baltimore LLC - EIR, 2021-04-20 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more